Flamel Technologies (FLML) in Focus: Stock Surges 11.8%

Zacks

Flamel Technologies SA (FLML) was a big mover last session, as the company saw its shares rise nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent trend of the company as the stock is now up 31.79% since Apr 15.

This med-drug industry stock witnessed no estimate revisions over the past 30 days. The Zacks Consensus Estimate however moved north over the same time, suggesting that more solid trading could be ahead for Flamel Technologies. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Flamel Technologies carries a Zacks Rank #3 (Hold), while its Earnings ESP is positive.

However, some better-ranked stocks in the same industry include Enanta Pharmaceuticals, Inc. (ENTA), Grifols, S.A. (GRFS) and Salix Pharmaceuticals Ltd. (SLXP). All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>





FLAMEL TECHNOLOGIES ADS (FLML): Free Stock Analysis Report

ENANTA PHARMACEUTICALS INC (ENTA): Free Stock Analysis Report

GRIFOLS SA ADS (GRFS): Free Stock Analysis Report

SALIX PHARMACEUTICALS LTD (SLXP): Free Stock Analysis Report


Zacks Investment Research

View Comments (0)